Detalhe da pesquisa
1.
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.
J Antimicrob Chemother
; 78(1): 117-121, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272137
2.
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study.
HIV Med
; 20(2): 164-168, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457197
3.
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.
HIV Med
; 2018 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29573320
4.
Morning dosing for dolutegravir-related insomnia and sleep disorders.
HIV Med
; 19(5): e62-e63, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28762661
5.
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study.
Int J Antimicrob Agents
; 54(4): 487-490, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195121
6.
Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.
Emerg Microbes Infect
; 11(1): 786-789, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209808
7.
HIV disease treatment in the era of HAART.
Biomed Pharmacother
; 53(2): 93-105, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10337464
8.
Employment of recombinant human granulocyte-macrophage colony stimulating factor in oesophageal candidiasis in AIDS patients.
AIDS
; 9(12): 1378-9, 1995 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-8605060
9.
Hypersensitivity reactions during antiretroviral regimens with protease inhibitors.
AIDS
; 11(10): 1301-2, 1997 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9256955
10.
Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients.
AIDS
; 12(9): 1111, 1998 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-9662213
11.
[Disseminated pneumocystosis. 3 cases in HIV seropositive patients]. / Pneumocystose disséminée. 3 cas chez des malades séropositifs pour le VIH.
Presse Med
; 22(21): 1013, 1993 Jun 12.
Artigo
em Francês
| MEDLINE | ID: mdl-8367433
12.
Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
Infection
; 35(6): 451-6, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18034204
13.
Plasma concentration of cytokine antagonists in patients with HIV infection.
Neuroimmunomodulation
; 1(1): 42-9, 1994 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8528884
14.
Lipid-based amphotericin B in the treatment of cryptococcosis.
Infection
; 22(2): 137-42, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7915255
15.
Intractable pruritus in HIV infection: immunologic characterization.
Allergy
; 54(3): 266-72, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10321563
16.
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons.
J Infect Dis
; 175(5): 1210-5, 1997 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-9129088
17.
[Primary treatment of cryptococcosis in AIDS: itraconazole in single dose or combined with 5-fluorocytosine]. / Terapia primaria della criptococcosi nell'AIDS: itraconazolo in monoterapia o associato alla 5-fluorocitosina.
G Ital Chemioter
; 38(1-3): 199-200, 1991.
Artigo
em Italiano
| MEDLINE | ID: mdl-1365593